Robbins Headache Clinic Blog
“What You Need to Know About Ubrelvy, First Acute CGRP Med Approved” from MigraineAgain.com
Adults with Migraine have new reason to be hopeful. 2019 saw FDA approval of new acute Migraine medications, and 2020 will be the year thousands of adults with Migraine with or without aura will get to try new meds like Ubrelvy (ubreogepant). Ubrelvy is an oral CGRP...
“Pharmacists Make Mistakes. You Can Protect Yourself” from The New York Times
Lynne Calloway had been taking a newly refilled arthritis prescription for a few days when she mentioned she wasn’t feeling well. So her husband, Joseph Calloway, did some investigating. When he looked up her medication in a book detailing prescription drugs, he said,...
“Study: Meditation May Be Better for Migraine Headaches Than Mental Distraction – But it Takes Time” from PsyPost
Active meditative techniques appear to be more effective at reducing migraine severity than distraction techniques, according to research published in the journal Complementary Therapies in Medicine. “Meditation practice has been associated with improved pain...
CGRP’s: Facebook Live presentation by Dr. R.
I am doing a FB Live(altho it will be on their site, archived) Monday Feb.3, 6PM central; it is thru the FB chat group: Hope for Migraine Community: CGRP and Emerging Treatments You probably need to join the group to view it.........I will talk about the new...
“Keeping Aging Muscles Fit is Tied to Better Heart Health Later” from The New York Times
For men at least, entering middle age with plenty of muscle may lower the later risk of developing heart disease by more than 80 percent. How much muscle you have now could indicate how healthy your heart will be later, according to an interesting new study of muscle...
“Some Excedrin Migraine Products May Be Temporarily Halted” from Healthline
Excedrin migraine medications are some of the most commonly used drugs to treat migraine headaches. However, people who suffer from the intense, painful headaches may have to try new treatments for a bit. Manufacturer GlaxoSmithKline (GSK) has temporarily halted...
“Comparison of Ubrogepant vs Placebo in Acute Migraine” from Neurology Advisor
Treatment with the orally administered, small-molecule calcitonin gene-related peptide receptor antagonist ubrogepant in patients with acute migraine has been associated with freedom from pain and the absence of the patient-determined most troublesome symptom compared...
“A (Former) Night Owl’s Guide to Becoming a Morning Person” from The New York Times
The world isn’t made for night owls. You struggle into work in the dark hours before 10 a.m. — or your morning coffee — and you’re greeted by some chipper person who has already been to the gym and is six items into his to-do list. I used to fantasize about fitting...
“Study Sheds Light on Link Between Cannabis, Anxiety and Stress” from Science Daily
A molecule produced by the brain that activates the same receptors as marijuana is protective against stress by reducing anxiety-causing connections between two brain regions, Vanderbilt University Medical Center researchers report. This finding, published today...
“Managing Migraines – As the Flyers’ Nolan Patrick is learning…” from Philly Voice
Bodily injuries are an ever-present workplace hazard for professional athletes, a fact Philadelphia sports fans have been reminded of this week. Like Carson Wentz's concussion that ended the Eagles' playoff run and Sixers center Joel Embiid's grusomely dislocated ring...